Overview

Perfluorocarbon (ABL-101) Oxygenation for Stroke: Trial With GOLD (Glasgow Oxygen Level Dependent Technology) Imaging Theranostic

Status:
Unknown status
Trial end date:
2020-03-01
Target enrollment:
Participant gender:
Summary
This study evaluates the safety and tolerability of 3 dose levels of ABL-101 and supplemental oxygen in acute stroke patients.
Phase:
Phase 2
Details
Lead Sponsor:
NHS Greater Glasgow and Clyde
Collaborators:
Aurum Biosciences Ltd
University of Glasgow